Orthopedic Biomaterials Market Size, Share and Trend Analysis - Global - 2025-2031 - MedSuite - Includes: Bone Graft Substitutes Market, Orthopedic Growth Factors Market, and 3 more

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $9,995	492 Pages	iData Research, Inc.	January, 2025	IDR19804977

Best Price Guarantee
Price	from $9,995
Length	492 Pages
Publisher	iData Research, Inc.
Published Date	January, 2025
SKU	IDR19804977

The global orthopedic biomaterials device market was valued at $7.3 billion in 2024 and is expected to grow at a CAGR of 4.0%, reaching $9.6 billion by 2031.

This market includes multiple key segments:

Bone Graft Substitute Market (Allograft, Demineralized Bone Matrix (DBM), and Synthetic Bone Grafts)
Orthopedic Growth Factor Market
Orthopedic Cell Therapy Market (Bone Marrow Aspirate Concentrate, Platelet-Rich Plasma)
Hyaluronic Acid (HA) Viscosupplementation Market (Single-, Two-, Three-, and Five-Injection Cycles)
Orthopedic Cartilage Repair Market (Osteochondral Allograft, Meniscal Allograft, Autologous Chondrocyte Implantation, and Osteochondral Autografts)

Market Insights & Data Coverage

Unit Sales & Average Selling Prices
Market Size & Growth Trends
Procedure Numbers
Market Drivers & Limiters
Market Forecasts Until 2031
Historical Data (2021-2023)
Competitive Landscape, Mergers & Acquisitions
Company Profiles & Product Portfolios

Market Trends

Aging Population Driving Market Growth:

The global population aged 60+ surpassed 1 billion in 2020 and is projected to reach 2.1 billion by 2050.
This demographic shift is expected to increase the demand for bone grafts and orthopedic biomaterials, especially for spinal fusion procedures due to age-related osteoarthritis and degenerative disc disease.

Growing Incidence of Osteoarthritis & Degenerative Conditions:

Higher rates of age-related diseases and rising obesity levels will drive demand for orthopedic biomaterials and restorative procedures.
Increased spinal fusion procedures will significantly boost the market for bone graft substitutes.

Advancements in Cell Therapy & Cartilage Repair:

Innovative therapies like platelet-rich plasma and bone marrow aspirate concentrates are expanding in regenerative medicine.
New cartilage repair techniques are improving patient outcomes and reducing the need for total joint replacements.

Market Share Insights

Top Competitors in the Global Orthopedic Biomaterials Market (2024):

1 Medtronic

Market leader in orthopedic biomaterials, particularly bone graft substitutes and orthopedic growth factors.
The INFUSE™ product line is a dominant player in the orthopedic growth factor market.

2 DePuy Synthes (Johnson & Johnson)

Second-largest market share, strong presence in bone graft substitutes and HA viscosupplementation.
Distributes leading HA products MONOVISC® and ORTHOVISC®, manufactured by Anika Therapeutics.

3 Fidia

Specializes in the HA viscosupplementation market with a five-injection product (HYALGAN®) and the first-ever two-injection product (Hymovis®) in the U.S.
TRILURON® – A pre-filled HA sodium salt product for knee osteoarthritis treatment.
The two-injection segment is experiencing rapid growth as lower-injection treatment trends gain traction.

Market Segmentation Summary

Bone Graft Substitute Market
Material Type: Allograft, Demineralized Bone Matrix, Synthetic Substitutes
Orthopedic Growth Factor Market
Indication Type: Cervical Disc Degeneration, Tibial Fracture, Spine, Ankle & Hindfoot Fusions
Orthopedic Cell Therapy Market
Material Type: Platelet-Rich Plasma, Bone Marrow Aspirate Concentrates
Hyaluronic Acid (HA) Viscosupplementation Market
Material Type: Single-Injection, Two-Injection, Three-Injection, Five-Injection Cycles
Orthopedic Cartilage Repair Market
Treatment Type: Osteochondral Allograft, Meniscal Allograft, Autologous Chondrocyte Implantation, Osteochondral Autografts

Global Research Scope

Regions Covered:
North America (U.S., Canada)
Latin America (Brazil, Mexico, Argentina, Colombia, Chile)
Western Europe (Germany, France, U.K., Spain, Italy)
Central & Eastern Europe (Poland, Russia, Turkey, Hungary)
Middle East (Saudi Arabia, UAE, Israel)
Asia Pacific (China, Japan, India, South Korea, Australia)
Africa (South Africa, Egypt, Nigeria, Kenya)
Base Year: 2024
Forecast Period: 2025-2031
Historical Data: 2021-2023

Quantitative Coverage

Market Size, Market Shares
Market Forecasts, Growth Rates
Units Sold, Average Selling Prices
Procedure Numbers

Qualitative Coverage

COVID-19 Impact
Market Growth Trends & Limiters
Competitive Analysis & SWOT for Top Competitors
Mergers & Acquisitions
Company Profiles & Product Portfolios
FDA Recalls, Disruptive Technologies
Disease Overviews

Data Sources:

Primary Interviews with Industry Leaders
Government Physician Data & Regulatory Data
Hospital Private Data
Import & Export Data
iData Research Internal Database

Executive Summary
Global Orthopedic Biomaterials Device Market Overview: Competitive Analysis; Emerging Markets and Technologies; Market Developments; Market Trends; Procedure Segmentation; Market Segmentation; Regions Included; Key Report Updates; Version History
research methodology: Step 1: Project Initiation & Team Selection; Step 2: Prepare Data Systems and Perform Secondary Research; Step 3: Preparation for Interviews & Questionnaire Design; Step 4: Performing Primary Research; Step 5: Research Analysis: Establishing Baseline Estimates; Step 6: Market Forecast and Analysis; Step 7: Identify Strategic Opportunities; Step 8: Final Review and Market Release; Step 9: Customer Feedback and Market Monitoring
Product Assessment: 2.1 Introduction; 2.2 Product Portfolios; 2.3 Regulatory Issues and Recalls; 2.4 Clinical Trials
Global Orthopedic Biomaterials Device Market Overview: 3.1 Introduction; 3.2 Market Overview & Trend Analysis; 3.3 Drivers and Limiters; 3.4 Competitive Market Share Analysis; 3.5 Mergers and Acquisitions; 3.6 Company Profiles; 3.7 SWOT Analysis
Orthopedic Bone Graft Substitute Market: 4.1 Executive Summary; 4.2 Introduction; 4.3 Procedure Numbers; 4.4 Market Overview; 4.5 Market Analysis and Forecast; 4.6 Unit Analysis; 4.7 Drivers and Limiters; 4.8 Competitive Market Share Analysis
Orthopedic Growth Factor Market: 5.1 Executive Summary; 5.2 Introduction; 5.3 Procedure Numbers; 5.4 Market Analysis and Forecast; 5.5 Unit Analysis; 5.6 Drivers and Limiters; 5.7 Competitive Market Share Analysis
Orthopedic Cell Therapy Market: 6.1 Executive Summary; 6.2 Introduction; 6.3 Procedure Numbers; 6.4 Market Overview; 6.5 Market Analysis and Forecast; 6.6 Unit Analysis; 6.7 Drivers and Limiters; 6.8 Competitive Market Share Analysis
Hyaluronic Acid Viscosupplementation Market: 7.1 Executive Summary; 7.2 Introduction; 7.3 Procedure Numbers; 7.4 Market Overview; 7.5 Market Analysis and Forecast; 7.6 Drivers and Limiters; 7.7 Competitive Market Share Analysis
Orthopedic Cartilage Repair Market: 8.1 Executive Summary; 8.2 Introduction; 8.3 Procedure Numbers; 8.4 Market Overview; 8.5 Market Analysis and Forecast; 8.6 Drivers and Limiters; 8.7 Competitive Market Share Analysis
Abbreviations: Chart 1-1: Orthopedic Biomaterials Device Market by Segment, Global, 2024 – 2031; Chart 1-2: Orthopedic Bone Graft Substitute Procedures, Global, 2024; Chart 3-1: Orthopedic Biomaterials Device Market by Segment, Global, 2021 – 2031; Chart 3-2: Orthopedic Biomaterials Device Market by Region, Global, 2021 – 2031; Chart 3-3: Leading Competitors, Orthopedic Biomaterials Device Market, Global, 2024; Chart 4-1: Orthopedic Bone Graft Substitute Market, Global, 2024 & 2031; Chart 4-2: Orthopedic Bone Graft Substitute Procedures, Global, 2024; Chart 4-3: Orthopedic Bone Grafting Procedures by Segment, Global, 2021– 2031; Chart 4-4: Orthopedic Bone Graft Substitute Device Market by Segment, Global, 2021 – 2031; Chart 4-5: Orthopedic Bone Graft Substitute Device Market by Region, Global, 2021 – 2031; Chart 4-6: Leading Competitors, Orthopedic Bone Graft Substitute Market, Global, 2024; Chart 5-1: Orthopedic Growth Factor Market, Global, 2024 & 2031; Chart 5-2: Orthopedic Growth Factor Procedures, Global, 2024; Chart 5-3: Orthopedic Growth Factor Procedures by Segment, Global, 2021 – 2031; Chart 5-4: Orthopedic Growth Factor Device Market, Global, 2021 – 2031; Chart 5-5: Leading Competitors, Orthopedic Growth Factor Market, Global, 2024; Chart 6-1: Orthopedic Cell Therapy Market, Global, 2024 & 2031; Chart 6-2: Orthopedic Cell Therapy Procedures, Global, 2024; Chart 6-3: Orthopedic Cell Therapy Procedures by Region, Global, 2021 – 2031; Chart 6-4: Orthopedic Cell Therapy Market by Segment, Global, 2021 – 2031; Chart 6-5: Orthopedic Cell Therapy Market by Region, Global, 2021 – 2031; Chart 6-6: Leading Competitors, Orthopedic Cell Therapy Market, Global, 2024; Chart 7-1: Hyaluronic Acid Viscosupplementation Market, Global, 2024 & 2031; Chart 7-2: Hyaluronic Acid Viscosupplementation Procedures, Global, 2024; Chart 7-3: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Region, Global, 2021 – 2031; Chart 7-4: Hyaluronic Acid Viscosupplementation Device Market by Segment, Global, 2021 – 2031; Chart 7-5: Hyaluronic Acid Viscosupplementation Device Market by Region, Global, 2021 – 2031; Chart 7-6: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Global, 2024; Chart 8-1: Orthopedic Cartilage Repair Market, Global, 2024 & 2031; Chart 8-2: Orthopedic Cartilage Repair Procedures, Global, 2024; Chart 8-3: Orthopedic Cartilage Repair Procedures by Segment, Global, 2021 – 2031; Chart 8-4: Orthopedic Cartilage Repair Device Market by Segment, Global, 2021 – 2031; Chart 8-5: Orthopedic Cartilage Repair Device Market by Region, Global, 2021 – 2031; Chart 8-6: Leading Competitors, Cartilage Repair Market, Global, 2024; Figure 1-1: Orthopedic Biomaterials Device Market Share Ranking by Segment, Global, 2024; Figure 1-2: Companies Researched in This Report (1 of 2); Figure 1-3: Companies Researched in This Report (2 of 2); Figure 1-4: Recent Events in the Orthopedic Biomaterials Device Market, Global, 2022 – 2024 (1 of 11); Figure 1-5: Recent Events in the Orthopedic Biomaterials Device Market, Global, 2022 – 2024 (3 of 11); Figure 1-6: Recent Events in the Orthopedic Biomaterials Device Market, Global, 2022 – 2024 (4 of 11); Figure 1-7: Recent Events in the Orthopedic Biomaterials Device Market, Global, 2022 – 2024 (5 of 11); Figure 1-8: Recent Events in the Orthopedic Biomaterials Device Market, Global, 2022 – 2024 (6 of 11); Figure 1-9: Recent Events in the Orthopedic Biomaterials Device Market, Global, 2022 – 2024 (7 of 11); Figure 1-10: Recent Events in the Orthopedic Biomaterials Device Market, Global, 2022 – 2024 (8 of 11); Figure 1-11: Recent Events in the Orthopedic Biomaterials Device Market, Global, 2022 – 2024 (9 of 11); Figure 1-12: Recent Events in the Orthopedic Biomaterials Device Market, Global, 2022 – 2024 (10 of 11); Figure 1-13: Recent Events in the Orthopedic Biomaterials Device Market, Global, 2022 – 2024 (11 of 11); Figure 1-14: Factors Impacting the Orthopedic Biomaterials Device Market by Segment, Global; Figure 1-15: Orthopedic Biomaterial Procedure Segmentation; Figure 1-16: Orthopedic Biomaterial Regions Covered, Global (1 of 2); Figure 1-17: Orthopedic Biomaterial Regions Covered, Global (2 of 2); Figure 1-18: Key Report Updates; Figure 1-19: Version History; Figure 2-1: Bone Graft Substitute Products by Company (1 of 4); Figure 2-2: Bone Graft Substitute Products by Company (2 of 4); Figure 2-3: Bone Graft Substitute Products by Company (3 of 4); Figure 2-4: Bone Graft Substitute Products by Company (4 of 4); Figure 2-5: Growth Factor Products by Company; Figure 2-6: Cell Therapy Products by Company; Figure 2-7: Hyaluronic Acid Viscosupplementation by Products by Company; Figure 2-8: Cartilage Repair Products by Company; Figure 2-9: Class 2 Device Recall GRAFTON DBM (Gel, Flex, Putty, Matrix, Crunch); Figure 2-10: Class 2 Device Recall GRAFTON PLUS DBM Paste; Figure 2-11: Class 2 Device Recall Magnifuse Bone Graft; Figure 2-12: Class 2 Device Recall Grafton DBF Inject; Figure 2-13: Class 2 Device Recall OsteoSelect Demineralized Bone Matrix (DBM) Putty; Figure 2-14: Class 2 Device Recall PROSTIM 10cc INJECTABLE; Figure 2-15: Class 2 Device Recall Opteform Allograft Disc; Figure 2-16: Class 2 Device Recall Bioactive Bone Graft Putty; Figure 2-17: Class 3 Device Recall iFACTOR Peptide Enhanced Bone Graft Putty; Figure 2-18: ACDF Using Structural Allograft vs. Tritanium C; Figure 2-19: Clinical Study of Bone Graft Substitutes in Orthopaedic and Spinal Applications; Figure 2-20: OSTEOAMP Lumbar Fusion Intra-Patient Controlled Study; Figure 2-21: Rate of Bony Fusion Using NanoBone® Synthetic Bone Graft Versus Local Autologous Bone Graft. (BONE); Figure 2-22: Demineralized Bone Matrix Rotator Cuff Study; Figure 2-23: Clinical Outcomes Associated with the Use of ViviGen® for the Treatment of Lumbar Degenerative Disc Disease; Figure 2-24: The Effect of Bone-void Filler on Anterior Knee Pain Following ACL Reconstruction; Figure 2-25: Long-term Safety and Effectiveness of AUGMENT® Injectable Bone Graft Compared to Autologous Bone Graft; Figure 2-26: Transforaminal Lumbar Interbody Fusion (TLIF); Figure 2-27: A Post Market Surveillance on INFUSE Bone Graft; Figure 2-28: Long-term Safety and Effectiveness of AUGMENT® Injectable Bone Graft Compared to Autologous Bone Graft; Figure 2-29: Evaluation of the Effectiveness of AMPLEX® Compared to Autogenous Bone Grafts; Figure 2-30: Effect of PRP, PPP, & BMAC on Functional Outcomes Following Hip Arthroscopy for Acetabular Labral Pathologies; Figure 2-31: Bone Marrow Aspirate Concentrate (BMAC) vs Corticosteroid Injection; Figure 2-32: BMAC & Allograft vs BMP-2; Figure 2-33: Bone Marrow Aspirate Concentrate (BMAC)Treatment for Knee Osteoarthritis (BMAC); Figure 2-34: Platelet Rich Plasma in Knee Osteoarthritis; Figure 2-35: Platelet-Rich Plasma (PRP) for Treatment of Symptomatic Lumbar Facet Syndrome of the Spine; Figure 2-36: A Prospective Study of Clinical Outcomes Following a Single Intradiscal Injection of Bone Marrow Aspirate Concentrate (BMAC) for Single Level Discogenic Low Back Pain; Figure 2-37: ArtiAid® for Knee Osteoarthritis: A Post-market Study; Figure 2-38: The Effectiveness of Different Doses of Hyaluronic Acid Injections in Knee Osteoarthritis; Figure 2-39: Euflexxa for the Treatment of Osteoarthritis; Figure 2-40: MONOVISC for Ankle Joint Pain Relief; Figure 2-41: MONOVISC for Shoulder Joint Pain Relief; Figure 2-42: MONOVISC for Hip Joint Pain Relief; Figure 2-43: Comparison of Hyaluronic Acid and Platelet-Rich Plasma Injections; Figure 2-44: Prospective Evaluation of ProChondrix CR for Repair of Articular Cartilage Defects on Femoral Condyle and Patella; Figure 2-45: Osteochondral Allograft in the Surgical Treatment of Basal Joint Arthritis; Figure 2-46: Phase 2 Clinical Trial of CartiLife® in the United States; Figure 2-47: A Study to Evaluate the Efficacy of BioCartilage® Micronized Cartilage Matrix in Microfracture Treatment of Osteochondral Defects; Figure 3-1: Orthopedic Biomaterials Device Market by Segment, Global, 2021 – 2031 (US$M); Figure 3-2: Orthopedic Biomaterials Device Market by Region, Global, 2021 – 2031 (US$M); Figure 3-3: Leading Competitors, Orthopedic Biomaterials Device Market by Segment, Global, 2024; Figure 3-4: Other Notable Competitors, Orthopedic Biomaterials Device Market by Segment, Global, 2024; Figure 3-5: SWOT Analysis, Arthrex; Figure 3-6: SWOT Analysis, Biocomposites; Figure 3-7: SWOT Analysis, Bioventus; Figure 3-8: SWOT Analysis, DePuy Synthes; Figure 3-9: SWOT Analysis, Ferring Pharmaceuticals; Figure 3-10: SWOT Analysis, Fidia Farmaceutici; Figure 3-11: SWOT Analysis, Harvest Technologies; Figure 3-12: SWOT Analysis, Medtronic; Figure 3-13: SWOT Analysis, MTF; Figure 3-14: SWOT Analysis, Orthofix; Figure 3-15: SWOT Analysis, Sanofi; Figure 3-16: SWOT Analysis, Sanofi; Figure 3-17: SWOT Analysis, Stryker; Figure 3-18: SWOT Analysis, Vericel Corporation; Figure 3-19: SWOT Analysis, Surgalign Holdings; Figure 3-20: SWOT Analysis, Zimmer Biomet; Figure 4-1: Orthopedic Bone Graft Substitute Regions Covered, Global (1 of 2); Figure 4-2: Orthopedic Bone Graft Substitute Regions Covered, Global (2 of 2); Figure 4-3: Orthopedic Bone Grafting Procedures by Segment, Global, 2021 – 2031; Figure 4-4: Orthopedic Bone Grafting Procedures by Region, Global, 2021 – 2031; Figure 4-5: Orthopedic Bone Grafting Procedures by Country, North America, 2021 – 2031; Figure 4-6: Orthopedic Bone Grafting Procedures by Country, Latin America, 2021 – 2031 (1 of 2); Figure 4-7: Orthopedic Bone Grafting Procedures by Country, Latin America, 2021 – 2031 (2 of 2); Figure 4-8: Orthopedic Bone Grafting Procedures by Country, Western Europe, 2021– 2031; Figure 4-9: Orthopedic Bone Grafting Procedures by Country, Central & Eastern Europe, 2021 – 2031 (1 of 2); Figure 4-10: Orthopedic Bone Grafting Procedures by Country, Central & Eastern Europe, 2021 – 2031 (2 of 2); Figure 4-11: Orthopedic Bone Grafting Procedures by Country, Middle East, 2021 – 2031; Figure 4-12: Orthopedic Bone Grafting Procedures by Country, Asia-Pacific, 2021– 2031 (1 of 3); Figure 4-13: Orthopedic Bone Grafting Procedures by Country, Asia-Pacific, 2021 – 2031 (2 of 3); Figure 4-14: Orthopedic Bone Grafting Procedures by Country, Asia-Pacific, 2021 – 2031 (3 of 3); Figure 4-15: Orthopedic Bone Grafting Procedures by Country, Africa, 2021 – 2031; Figure 4-16: Allograft Procedures by Region, Global, 2021– 2031; Figure 4-17: Allograft Procedures by Country, North America, 2021– 2031; Figure 4-18: Allograft Procedures by Country, Latin America, 2021– 2031 (1 of 2); Figure 4-19: Allograft Procedures by Country, Latin America, 2021– 2031 (2 of 2); Figure 4-20: Allograft Procedures by Country, Western Europe, 2021 – 2031; Figure 4-21: Allograft Procedures by Country, Central & Eastern Europe, 2021 – 2031 (1 of 2); Figure 4-22: Allograft Procedures by Country, Central & Eastern Europe, 2021 – 2031 (2 of 2); Figure 4-23: Allograft Procedures by Country, Middle East, 2021– 2031; Figure 4-24: Allograft Procedures by Country, Asia-Pacific, 2021 – 2031 (1 of 3); Figure 4-25: Allograft Procedures by Country, Asia-Pacific, 2021 – 2031 (2 of 3); Figure 4-26: Allograft Procedures by Country, Asia-Pacific, 2021 – 2031 (3 of 3); Figure 4-27: Allograft Procedures by Country, Africa, 2021– 2031; Figure 4-28: Demineralized Bone Matrix Procedures by Region, Global, 2021– 2031; Figure 4-29: Demineralized Bone Matrix Procedures by Country, North America, 2021– 2031; Figure 4-30: Demineralized Bone Matrix Procedures by Country, Latin America, 2021– 2031 (1 of 2); Figure 4-31: Demineralized Bone Matrix Procedures by Country, Latin America, 2021– 2031 (2 of 2); Figure 4-32: Demineralized Bone Matrix Procedures by Country, Western Europe, 2021 – 2031; Figure 4-33: Demineralized Bone Matrix Procedures by Country, Central & Eastern Europe, 2021 – 2031 (1 of 2); Figure 4-34: Demineralized Bone Matrix Procedures by Country, Central & Eastern Europe, 2021 – 2031 (2 of 2); Figure 4-35: Demineralized Bone Matrix Procedures by Country, Middle East, 2021 – 2031; Figure 4-36: Demineralized Bone Matrix Procedures by Country, Asia-Pacific, 2021– 2031 (1 of 3); Figure 4-37: Demineralized Bone Matrix Procedures by Country, Asia-Pacific, 2021– 2031 (2 of 3); Figure 4-38: Demineralized Bone Matrix Procedures by Country, Asia-Pacific, 2021 – 2031 (3 of 3); Figure 4-39: Demineralized Bone Matrix Procedures by Country, Africa, 2021 – 2031; Figure 4-40: Synthetic Procedures by Region, Global, 2021 – 2031; Figure 4-41: Synthetic Procedures by Country, North America, 2021 – 2031; Figure 4-42: Synthetic Procedures by Country, Latin America, 2021 – 2031 (1 of 2); Figure 4-43: Synthetic Procedures by Country, Latin America, 2021 – 2031 (2 of 2); Figure 4-44: Synthetic Procedures by Country, Western Europe, 2021– 2031; Figure 4-45: Synthetic Procedures by Country, Central & Eastern Europe, 2021 – 2031 (1 of 2); Figure 4-46: Synthetic Procedures by Country, Central & Eastern Europe, 2021 – 2031 (2 of 2); Figure 4-47: Synthetic Procedures by Country, Middle East, 2021 – 2031; Figure 4-48: Synthetic Procedures by Country, Asia-Pacific, 2021 – 2031 (1 of 3); Figure 4-49: Synthetic Procedures by Country, Asia-Pacific, 2021 – 2031 (2 of 3); Figure 4-50: Synthetic Procedures by Country, Asia-Pacific, 2021 – 2031 (3 of 3); Figure 4-51: Synthetic Procedures by Country, Africa, 2021 – 2031; Figure 4-52: Orthopedic Bone Graft Substitute Device Market by Segment, Global, 2021 – 2031 (US$M); Figure 4-53: Orthopedic Bone Graft Substitute Device Market by Region, Global, 2021 – 2031 (US$M); Figure 4-54: Orthopedic Bone Graft Substitute Market, Global, 2021 – 2031; Figure 4-55: Units Sold by Region, Orthopedic Bone Graft Substitute Market, Global, 2021 – 2031; Figure 4-56: Average Selling Price by Region, Orthopedic Bone Graft Substitute Market, Global, 2021– 2031 (US$); Figure 4-57: Market Value by Region, Orthopedic Bone Graft Substitute Market, Global, 2021 – 2031 (US$M); Figure 4-58: Allograft Bone Graft Substitute Market, Global, 2021 – 2031; Figure 4-59: Units Sold by Region, Allograft Bone Graft Substitute Market, Global, 2021 – 2031; Figure 4-60: Average Selling Price by Region, Allograft Bone Graft Substitute Market, Global, 2021 – 2031 (US$); Figure 4-61: Market Value by Region, Allograft Bone Graft Substitute Market, Global, 2021 – 2031 (US$M); Figure 4-62: Demineralized Bone Matrix Allograft Bone Graft Substitute Market, Global, 2021 – 2031; Figure 4-63: Units Sold by Region, Demineralized Bone Matrix Allograft Bone Graft Substitute Market, Global, 2021 – 2031; Figure 4-64: Average Selling Price by Region, Demineralized Bone Matrix Allograft Bone Graft Substitute Market, Global, 2021 – 2031 (US$); Figure 4-65: Market Value by Region, Demineralized Bone Matrix Allograft Bone Graft Substitute Market, Global, 2021 – 2031 (US$M); Figure 4-66: Synthetic Bone Graft Substitute Market, Global, 2021 – 2031; Figure 4-67: Units Sold by Region, Synthetic Bone Graft Substitute Market, Global, 2021 – 2031; Figure 4-68: Average Selling Price by Region, Synthetic Bone Graft Substitute Market, Global, 2021 – 2031 (US$); Figure 4-69: Market Value by Region, Synthetic Bone Graft Substitute Market, Global, 2021 – 2031 (US$M); Figure 4-70: Generation 1 Synthetic Bone Graft Substitute Market, Global, 2021 – 2031; Figure 4-71: Units Sold by Region, Generation 1 Synthetic Bone Graft Substitute Market, Global, 2021 – 2031; Figure 4-72: Average Selling Price by Region, Generation 1 Synthetic Bone Graft Substitute Market, Global, 2021 – 2031 (US$); Figure 4-73: Market Value by Region, Generation 1 Synthetic Bone Graft Substitute Market, Global, 2021 – 2031 (US$M); Figure 4-74: Generation 2 Synthetic Bone Graft Substitute Market, Global, 2021 – 2031; Figure 4-75: Units Sold by Region, Generation 2 Synthetic Bone Graft Substitute Market, Global, 2021 – 2031; Figure 4-76: Average Selling Price by Region, Generation 2 Synthetic Bone Graft Substitute Market, Global, 2021 – 2031 (US$); Figure 4-77: Market Value by Region, Generation 2 Synthetic Bone Graft Substitute Market, Global, 2021 – 2031 (US$M); Figure 4-78: Allograft Bone Graft Substitute Units Sold by Indication, Global, 2021 – 2031; Figure 4-79: Spine Allograft Bone Graft Substitute Units Sold, Global, 2021 – 2031; Figure 4-80: Trauma Allograft Bone Graft Substitute Units Sold, Global, 2021 – 2031; Figure 4-81: Large Joint Reconstruction Allograft Bone Graft Substitute Units Sold, Global, 2021– 2031; Figure 4-82: Demineralized Bone Matrix Allograft Bone Graft Substitute Units Sold by Indication, Global, 2021 – 2031; Figure 4-83: Spine Demineralized Bone Matrix Allograft Bone Graft Substitute Units Sold, Global, 2021 – 2031; Figure 4-84: Trauma Demineralized Bone Matrix Allograft Bone Graft Substitute Units Sold, Global, 2021 – 2031; Figure 4-85: Large Joint Reconstruction Demineralized Bone Matrix Allograft Bone Graft Substitute Units Sold, Global, 2021 – 2031; Figure 4-86: Synthetic Bone Graft Substitute Units Sold by Indication, Global, 2021 – 2031; Figure 4-87: Spine Synthetic Bone Graft Substitute Units Sold, Global, 2021 – 2031; Figure 4-88: Trauma Synthetic Bone Graft Substitute Units Sold, Global, 2021 – 2031; Figure 4-89: Large Joint Reconstruction Synthetic Bone Graft Substitute Units Sold, Global, 2021 – 2031; Figure 4-90: Leading Competitors, Orthopedic Bone Graft Substitute Market, Global, 2024; Figure 5-1: Orthopedic Growth Factor Regions Covered, Global (1 of 2); Figure 5-2: Orthopedic Growth Factor Regions Covered, Global (2 of 2); Figure 5-3: Orthopedic Growth Factor Procedures by Region, Global, 2024 – 2031; Figure 5-4: Orthopedic Growth Factor Procedures by Country, North America, 2021 – 2031; Figure 5-5: Orthopedic Growth Factor Procedures by Country, Latin America, 2021 – 2031 (1 of 2); Figure 5-6: Orthopedic Growth Factor Procedures by Country, Latin America, 2021 – 2031 (2 of 2); Figure 5-7: Orthopedic Growth Factor Procedures by Country, Western Europe, 2021 – 2031; Figure 5-8: Orthopedic Growth Factor Procedures by Country, Central & Eastern Europe, 2021 – 2031 (1 of 2); Figure 5-9: Orthopedic Growth Factor Procedures by Country, Central & Eastern Europe, 2021 – 2031 (2 of 2); Figure 5-10: Orthopedic Growth Factor Procedures by Country, Middle East, 2021 – 2031; Figure 5-11: Orthopedic Growth Factor Procedures by Country, Asia-Pacific, 2021 – 2031 (1 of 3); Figure 5-12: Orthopedic Growth Factor Procedures by Country, Asia-Pacific, 2021 – 2031 (2 of 3); Figure 5-13: Orthopedic Growth Factor Procedures by Country, Asia-Pacific, 2021 – 2031 (3 of 3); Figure 5-14: Orthopedic Growth Factor Procedures by Country, Africa, 2021 – 2031; Figure 5-15: Orthopedic Growth Factor Market, Global, 2021 – 2031; Figure 5-16: Units Sold by Region, Orthopedic Growth Factor Market, Global, 2021 – 2031; Figure 5-17: Average Selling Price by Region, Orthopedic Growth Factor Market, Global, 2021 – 2031 (US$); Figure 5-18: Market Value by Region, Orthopedic Growth Factor Market, Global, 2021 – 2031 (US$M); Figure 5-19: Cervical Disc Degeneration Growth Factor Units Sold by Region, Global, 2021 – 2031; Figure 5-20: Tibial Fracture Growth Factor Units Sold by Region, Global, 2021 – 2031; Figure 5-21: Spine Growth Factor Units Sold by Region, Global, 2021 – 2031; Figure 5-22: Ankle & Hindfoot Fusion Growth Factor Units Sold by Region, Global, 2021 – 2031; Figure 5-23: Leading Competitors, Orthopedic Growth Factor Market, Global, 2024; Figure 6-1: Orthopedic Cell Therapy Regions Covered, Global (1 of 2); Figure 6-2: Orthopedic Cell Therapy Regions Covered, Global (2 of 2); Figure 6-3: Orthopedic Cell Therapy Procedures by Segment, Global, 2021 – 2031; Figure 6-4: Orthopedic Cell Therapy Procedures by Region, Global, 2021 – 2031; Figure 6-5: Orthopedic Cell Therapy Procedures by Country, North America, 2021– 2031; Figure 6-6: Orthopedic Cell Therapy Procedures by Country, Latin America, 2021 – 2031 (1 of 2); Figure 6-7: Orthopedic Cell Therapy Procedures by Country, Latin America, 2021 – 2031 (2 of 2); Figure 6-8: Orthopedic Cell Therapy Procedures by Country, Western Europe, 2021 – 2031; Figure 6-9: Orthopedic Cell Therapy Procedures by Country, Central & Eastern Europe, 2021 – 2031 (1 of 2); Figure 6-10: Orthopedic Cell Therapy Procedures by Country, Central & Eastern Europe, 2021 – 2031 (2 of 2); Figure 6-11: Orthopedic Cell Therapy Procedures by Country, Middle East, 2021 – 2031

PDF E-mail From Publisher:	$9,995
Multi-User 2-5 users:	$11,995
Global Site License Fulfilled by Publisher:	$13,995

Show additional purchase options...

Research Assistance

US: 800.298.5699

Int'l: +1.240.747.3093

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Orthopedic Biomaterials Market Size, Share and Trend Analysis - Global - 2025-2031 - MedSuite - Includes: Bone Graft Substitutes Market, Orthopedic Growth Factors Market, and 3 more

Orthopedic Biomaterials Market Size, Share and Trends Analysis - Europe - 2024-2030 - MedSuite - Includes: Bone Graft Substitutes, Orthopedic Growth Factors, and 3 more

Orthopedic Biomaterials Market Size, Share & Trends Analysis | United States | 2024-2030 | MedSuite | Includes: Bone Graft Substitutes, Orthopedic Growth Factors, Cellular Allografts, and 3 more

Dental Bone Graft Substitute Market Size, Share & COVID19 Impact Analysis | United States | 2023-2029 | MedSuite | Includes: Dental Bone Graft Substitutes, Dental Barrier Membranes, and 3 more

Dental Bone Graft Substitutes Market Size, Share & COVID-19 Impact Analysis-Europe-2023-2029-MedSuite-Includes: Dental Growth Factors, Dental Barrier Membranes (DBMs), and 2 more

Orthopedic Bone Graft Substitute Market Size, Share, and Trends Analysis - Global - 2025-2031 - MedCore - Includes: Allograft Market, Demineralized Bone Matrix Market, and 1 more

Dental Bone Graft Substitutes Market Size, Share & COVID-19 Impact Analysis-Latin America-2023-2029-MedSuite-Includes: Dental Bone Graft Substitutes Market, Dental Barrier Membranes Market and Antimicrobial Periodontal Treatment Market

Research Assistance

Other tasks